March is Colorectal Cancer Awareness Month, a time to elevate understanding about one of the most preventable—and treatable—forms of cancer when detected early. At Tower Cancer Research Foundation, we are committed not only to advancing innovative early-stage cancer research, but also to ensuring that individuals and families facing cancer have the support, resources, and community they need to thrive.
Colorectal cancer remains one of the most commonly diagnosed cancers among both men and women in the United States, with the fastest growing number of cases occurring in adults under the age of 50. While these numbers are sobering, there is also powerful hope: screening saves lives.
When detected early, colorectal cancer is highly treatable. In fact, regular screening can even prevent cancer by identifying and removing precancerous polyps before they develop into something more serious. Yet many people delay or avoid screening due to fear, stigma, or misunderstanding.
This month, we encourage everyone to:
Prevention and early detection are among the most effective tools we have in reducing cancer mortality.
Colorectal cancer often develops silently, with few noticeable symptoms in its earliest stages. Screening options—including colonoscopy and at-home tests—make it possible to detect cancer early, when treatment outcomes are strongest.
Screening guidelines now recommend beginning regular screening at age 45 for individuals at average risk, and earlier for those with a family history or other risk factors. Early action makes an extraordinary difference.
At Tower Cancer Research Foundation, our mission extends beyond the laboratory. We recognize that cancer impacts every aspect of a person’s life—physically, emotionally, and socially.
Through Magnolia House, our supportive care and survivorship center, we provide programs designed to nurture healing and resilience for those living with and surviving cancer through health and wellness, nutrition, and mental health programs.